Bill
Bill > HB1722
MS HB1722
MS HB1722Ivermectin; authorize pharmacists to provide to adults under collaborative pharmacy practice agreement.
summary
Introduced
01/19/2026
01/19/2026
In Committee
01/19/2026
01/19/2026
Crossed Over
Passed
Dead
02/03/2026
02/03/2026
Introduced Session
2026 Regular Session
Bill Summary
An Act To Authorize Pharmacists To Provide Ivermectin To Patients Who Are Eighteen Years Of Age Or Older Pursuant To A Valid Collaborative Pharmacy Practice Agreement Containing A Non-patient-specific Prescriptive Order And Standardized Procedures Developed And Executed By One Or More Authorized Practitioners; To Direct The Board Of Pharmacy To Adopt Rules To Establish Standard Procedures For The Provision Of Ivermectin By Pharmacists, Including Providing The Patient With A Screening Risk Assessment Tool, Providing The Patient With A Standardized Factsheet, And Either Dispensing The Ivermectin Or Referring The Patient To A Pharmacy That May Dispense The Medication As Soon As Practical; To Authorize The Charging Of An Administrative Fee For Services Provided Pursuant To This Act In Addition To Costs Associated With The Dispensing Of Ivermectin And Paid By The Pharmacy Benefit; To Provide That A Pharmacist Or Practitioner Acting In Good Faith And With Reasonable Care Involved In The Provision Of Ivermectin Pursuant To This Act Is Immune From Disciplinary Or Adverse Administrative Actions For Acts Or Omissions During The Provision Of Ivermectin; To Provide That A Pharmacist Or Practitioner Involved In The Provision Of Ivermectin Pursuant To This Act Is Immune From Civil Liability In The Absence Of Gross Negligence Or Willful Misconduct For Actions Authorized By This Act; And For Related Purposes.
AI Summary
This bill authorizes pharmacists to provide the drug ivermectin to adults aged 18 and older under a collaborative pharmacy practice agreement, which is a formal arrangement allowing pharmacists to provide certain medical services under the supervision of a physician or other authorized practitioner. The bill directs the Board of Pharmacy to create rules for pharmacists to follow, including giving patients a risk assessment tool and a factsheet about ivermectin, and then either dispensing the medication or referring the patient to another pharmacy. Pharmacists can charge an administrative fee for these services in addition to the cost of the medication. Importantly, pharmacists and practitioners involved in providing ivermectin under these new rules are protected from disciplinary actions and civil lawsuits, unless there is gross negligence or willful misconduct.
Committee Categories
Health and Social Services
Sponsors (1)
Last Action
Died In Committee (on 02/03/2026)
Official Document
bill text
bill summary
Loading...
bill summary
Loading...
bill summary
| Document Type | Source Location |
|---|---|
| State Bill Page | https://billstatus.ls.state.ms.us/2026/pdf/history/HB/HB1722.xml |
| BillText | https://billstatus.ls.state.ms.us/documents/2026/html/HB/1700-1799/HB1722IN.htm |
Loading...